SEMA3A
Semaphorin-3A
Also known as: coll-1, Hsema-I, SEM3A_HUMAN, SEMA1, SEMAD, SemD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14563
- Gene
- SEMA3A
- Ensembl
- ENSG00000075213
- Chromosome
- 7
- Canonical length
- 771 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
This gene is a member of the semaphorin family and encodes a protein with an Ig-like C2-type (immunoglobulin-like) domain, a PSI domain and a Sema domain. This secreted protein can function as either a chemorepulsive agent, inhibiting axonal outgrowth, or as a chemoattractive agent, stimulating the growth of apical dendrites. In both cases, the protein is vital for normal neuronal pattern development. Increased expression of this protein is associated with schizophrenia and is seen in a variety of human tumor cell lines. Also, aberrant release of this protein is associated with the progression of Alzheimer's disease. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
771 residues, UniProt reviewed canonical sequence.
>Q14563|SEMA3A
1 MGWLTRIVCL FWGVLLTARA NYQNGKNNVP RLKLSYKEML ESNNVITFNG LANSSSYHTF
61 LLDEERSRLY VGAKDHIFSF DLVNIKDFQK IVWPVSYTRR DECKWAGKDI LKECANFIKV
121 LKAYNQTHLY ACGTGAFHPI CTYIEIGHHP EDNIFKLENS HFENGRGKSP YDPKLLTASL
181 LIDGELYSGT AADFMGRDFA IFRTLGHHHP IRTEQHDSRW LNDPKFISAH LISESDNPED
241 DKVYFFFREN AIDGEHSGKA THARIGQICK NDFGGHRSLV NKWTTFLKAR LICSVPGPNG
301 IDTHFDELQD VFLMNFKDPK NPVVYGVFTT SSNIFKGSAV CMYSMSDVRR VFLGPYAHRD
361 GPNYQWVPYQ GRVPYPRPGT CPSKTFGGFD STKDLPDDVI TFARSHPAMY NPVFPMNNRP
421 IVIKTDVNYQ FTQIVVDRVD AEDGQYDVMF IGTDVGTVLK VVSIPKETWY DLEEVLLEEM
481 TVFREPTAIS AMELSTKQQQ LYIGSTAGVA QLPLHRCDIY GKACAECCLA RDPYCAWDGS
541 ACSRYFPTAK RRTRRQDIRN GDPLTHCSDL HHDNHHGHSP EERIIYGVEN SSTFLECSPK
601 SQRALVYWQF QRRNEERKEE IRVDDHIIRT DQGLLLRSLQ QKDSGNYLCH AVEHGFIQTL
661 LKVTLEVIDT EHLEELLHKD DDGDGSKTKE MSNSMTPSQK VWYRDFMQLI NHPNLNTMDE
721 FCEQVWKRDR KQRRQRPGHT PGNSNKWKHL QENKKGRNRR THEFERAPRS VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SEMA3A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- retina: 21 nTPM
- placenta: 9.7 nTPM
- colon: 9 nTPM
- adipose tissue: 6.4 nTPM
- esophagus: 5.5 nTPM
- rectum: 5.3 nTPM
Single-cell type
- lymphatic endothelial cells: 768 nCPM
- adipocytes: 513 nCPM
- gonadotrophs: 383 nCPM
- rod photoreceptor cells: 362 nCPM
- somatotrophs: 352 nCPM
- endometrial secretory cells: 349 nCPM
Immune cell
- non-classical monocyte: 1.5 nTPM
- intermediate monocyte: 0.3 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- basal ganglia: 22 nTPM
- pons: 20 nTPM
- white matter: 19 nTPM
- cerebral cortex: 16 nTPM
- medulla oblongata: 14 nTPM
- hypothalamus: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SEMA3A.
Disease | AllUniProt
Conditions SEMA3A is implicated in, by any mechanism.
- Hypogonadotropic hypogonadism 16 with or without anosmia (HH16) MIM:614897
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 390 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- SEMA3A-related disorder
- Hypogonadotropic hypogonadism 16 with or without anosmia
ReferencesPubMed · IEDB
Publications for SEMA3A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Semaphorin 4A antibody alleviates arsenic-induced hepatotoxicity in mice via inhibition of AKT2/NF-κB inflammatory signaling.
2021 · Toxicol Appl Pharmacol · RCR 0.6 · 7 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 1.75
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon extension involved in axon guidance
- axon guidance
- axonogenesis involved in innervation
- basal dendrite arborization
- branchiomotor neuron axon guidance
- facial nerve structural organization
- motor neuron axon guidance
- negative chemotaxis
- negative regulation of neuron projection development
- nerve development
- neural crest cell migration
- neural crest cell migration involved in autonomic nervous system development
- neuron migration
- olfactory bulb development
- positive regulation of cell migration
- positive regulation of JNK cascade
- regulation of axon extension involved in axon guidance
- semaphorin-plexin signaling pathway
- sensory system development
- sympathetic ganglion development
- sympathetic nervous system development
- sympathetic neuron projection extension
- sympathetic neuron projection guidance
- trigeminal nerve structural organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sema domain
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Immunoglobulin-like fold
- WD40/YVTN repeat-like-containing domain superfamily
- PSI domain
- Semaphorin
- Immunoglobulin-like domain superfamily
- Sema domain superfamily
- IL-1Ra-like, immunoglobulin domain
- Sema domain
- Immunoglobulin domain
- Semaphorin-3A, sema domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SEMA3A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SEMA3A as an antibody target. Whether an autoantibody or antibody against SEMA3A could matter depends on whether native SEMA3A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SEMA3A is annotated as secreted, so native SEMA3A circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SEMA3A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...